Drreddys
Bookmark
ShareCopied to clipboardDrreddys is a company. It is a public company in Hyderabad, India. It was founded in 1984 and its current CEO is Erez Israeli. It is part of the Health Care sector, specifically in the Pharmaceuticals industry.
Key facts
- city: Hyderabad
- country: India
- employees: 27,048 people
- revenues: 3.6B $
- company type: public
- sector: Health Care
- industry: Pharmaceuticals
- foundation year: 1984
- CEO: Erez Israeli
- CEO approval: 89 %
- ESG score: Try Pro to see estimate
See more facts
Extract data
Download datasets about Drreddys:
Dataset of stocks from Drreddys:
Drreddys is one of the companies in India, companies in Pharmaceuticals, companies in Health Care, companies in Hyderabad and 3,456,808 companies in our database.
Talking Points
- Dr. Reddy’s Laboratories – Good Health Can’t Wait
- Dr. Reddy’s Laboratories, a leading multinational pharmaceutical company based in India and overseas, committed to providing affordable and innovative medicines for healthier lives.
- We accelerate access to affordable and innovative medicines because Good Health Can't Wait. | Dr. Reddy's Laboratories Ltd. is an integrated pharmaceutical company, committed to providing affordable and innovative medicines for healthier lives. Through its three businesses - Pharmaceutical Services & Active Ingredients, Global ...
- Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics segment manufactures and markets prescription and over-the-counter finished pharmaceutical products that are marketed under a brand name or as a generic finished dosages with therapeutic equivalence to branded formulations. This segment also engages in the biologics business. The PSAI segment manufactures and markets active pharmaceutical ingredients and intermediates, which are principal ingredients for finished pharmaceutical products. This segment also provides contract research services; and manufactures and sells active pharmaceutical ingredients and steroids in accordance with the specific customer requirements. Its Proprietary Products segment focuses on the research and development of differentiated formulations. The Others segment engages in developing therapies in the fields of oncology and inflammation. The therapeutic categories primarily include gastro-intestinal, cardiovascular, anti-diabetic, dermatology, oncology, respiratory, stomatology, urology, and nephrology. The company has a collaboration, license, and option agreement with Curis, Inc. to discover, develop, and commercialize small molecule antagonists for immuno-oncology and precision oncology targets. Dr. Reddy's Laboratories Limited was incorporated in 1984 and is headquartered in Hyderabad, India.